BOLTON SECURITIES CORPORATION’s Pfizer PFE Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.69M	Buy	+66,529	New	+$1.74M	0.1%	225

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's PFE Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Pfizer (PFE) in Q1 2025: 66,529 shares worth $1.69M. The stake represents 0.1% of the portfolio and ranks #225 among its holdings.

2,944 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

BOLTON SECURITIES CORPORATION held 66,529 shares of Pfizer worth $1.69M as of Q1 2025.
Pfizer was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
Pfizer made up 0.1% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #225 holding.
2,944 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.